Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Do the patients with coronary artery disease have the same benefits from transcatheter aortic valve implantation?
Session:
Posters 2 - Écran 02 - Intervenção não Coronária
Speaker:
Paulo Maia Araújo
Congress:
CPC 2018
Topic:
H. Interventional Cardiology and Cardiovascular Surgery
Theme:
25. Interventional Cardiology
Subtheme:
25.3 Non-coronary Cardiac Intervention
Session Type:
Posters
FP Number:
---
Authors:
Paulo Maia Araújo; Alzira Nunes; Sofia Torres; Marta Braga; Roberto Pinto; Joana Duarte Rodrigues; Rui Rodrigues; Pedro Bernardo Almeida; Manuel Campelo; JOAO SILVA; Maria Júlia Maciel Barbosa
Abstract
<p><strong>Introduction: </strong>Transcatheter aortic valve implantation (TAVI) is an effective treatment for symptomatic severe aortic stenosis, considered at high surgical risk. Coronary artery disease (CAD) is a frequent comorbidity in these patients (pts) and can influence the results of this procedure.</p> <p><strong>Purpose: </strong>To evaluate if the beneficial effects of TAVI on morbi/mortality and on the symptoms improvement are comparable in patients with or without CAD.</p> <p><strong>Methods: </strong>We retrospectively evaluated pts submitted to TAVI in our hospital between October 2014 and December 2016. All pts had symptomatic severe aortic stenosis prior to the procedure and the decision for referral for TAVI was made by a multidisciplinary <em>Heart Team</em>. CAD was defined as the presence of obstructive lesions (any stenosis ≥70% or left main [LM] stenosis ≥50%).</p> <p><strong>Results: </strong>During this period, 89 pts were submitted to TAVI, with a mean age of 80.2±7.1 years, of whom 51.7% (n=46) were female. Forty two pts (47.2%) had CAD: one vessel in 19.1%; 2 vessels in 4.5%; 3 vessels in 5.6%; involvement of LM in 33%. Of this group, 47.6% had been previously submitted to PCI and 35.7% to CABG. Additionally, in fifteen pts (35.7% of CAD group) periprocedural PCI was performed.</p> <p>Baseline characteristics weren’t significantly different between pts with/wihout CAD regarding to age (81.1 vs 79.5 years; p=0.69), sex (45.2% vs 57.4% female; p=0.25), left ventricular ejection fraction (55.0% vs 50.7%; p=0.66), NYHA class ≥2 (97.6% vs 100%; p=0.29) or presence of angina (26.2% vs 14.9%; p=0.19). As expected, EuroScore II was higher in CAD pts (7.8% vs 3.8%; p<0.01).</p> <p>Incidence of intra/postprocedural complications was similar between CAD pts vs no CAD: 64.3% vs 68.1% (p= 0.71). However, mean stay was higher in CAD pts (15.3 vs 12.4 days; p= 0.01). Only one patient had in-hospital mortality (no CAD).</p> <p>During a mean time of follow-up of 386±93 days after discharge, CAD pts had similar rates of all-causes mortality (9.8% vs 4.3%, p=0.32), but cardiovascular mortality was tendentially higher (7.3% vs 0%), although not reaching statistical significance (p=0.06).</p> <p>CAD group had higher rates of hospitalizations: 39.0% vs 19.6% (p=0.05).</p> <p>At one year after discharge, in the CAD group, TAVI resulted in a significant reduction of angina (pre-TAVI: 26.2% vs post-TAVI 5.7%; p<0.01) and of NYHA class ≥2 (pre-TAVI: 97.6% vs post-TAVI 37.1%; p<0.01). The proportion of pts reporting an overall improvement in functional capacity after the procedure was high, with similar rates between pts with or without CAD: 85.7% vs 76.7% (p=0.32).</p> <p><strong>Conclusion: </strong>In this population, the presence of CAD was associated with higher morbidity and a tendency to higher cardiovascular mortality after TAVI. However, this procedure successfully improved symptoms and functional capacity in CAD group, similarly to the other pts. Therefore, TAVI has important clinical benefits even in pts with CAD.</p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site